en ENGLISH
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Bieżący numer Archiwum Filmy Artykuły w druku O czasopiśmie Suplementy Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury
4/2021
vol. 123
 
Poleć ten artykuł:
Udostępnij:
więcej
 
 
streszczenie artykułu:
Artykuł oryginalny

Anatomical and functional outcomes of treatment for retinopathy of prematurity (ROP) in zone I

Anna Chmielarz-Czarnocińska
1
,
Marta Pawlak
1
,
Anna Rzeszotarska
1
,
Dawid Szpecht
2
,
Marta Szymankiewicz-Bręborowicz
2
,
Anna Gotz-Więckowska
1

1.
Department of Ophthalmology, Poznan University of Medical Sciences, Poznan, Poland
2.
Department of Neonatology, Poznan University of Medical Sciences, Poznan, Poland
KLINIKA OCZNA 2021, 123, 4: 203–209
Data publikacji online: 2021/12/17
Pełna treść artykułu
Pobierz cytowanie
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 


Aim
To assess treatment methods of zone I retinopathy of prema¬turity (ROP) and evaluate anatomical, functional and refractive outcomes of patients after the treatment.

Material and methods
The anatomical outcomes were evaluated retrospectively for all patients born and treated for zone I ROP in the Gynecology and Obstetrics Hospital of Poznan University of Medical Sciences in 2016-2019. Functional and refractive out¬comes were assessed for the patients who remained in follow-up after 12 months of corrected age.

Results
Forty-five eyes of 25 patients were included in the study. Two infants (3 eyes, 6.7%) were treated with laser photocoagula¬tion (LP), 8 infants (15 eyes, 33.3%) had ranibizumab injections (IVR), 15 infants (27 eyes, 60.0%) had IVR followed by LP. Forty-one eyes (91.1%) of 23 patients had favorable anatomical outcomes characterized by an attached retina and plus disease regression. In 34 eyes of 19 patients, visual reactions, visual acuity (VA), and re-fractive error were assessed. The mean follow-up time was 36 ±17.4 months (16-64 months). In 17 patients (89.5%), visual responses were present. The mean VA for the 9 eyes tested with Lea opto¬types was logMAR 0.5±2.4 (0.5-0.1). The cycloplegic autorefractor measurements revealed: hyperopia in 2 eyes, physiological hypero¬pia/emmetropia in 8 eyes, myopia in 24 eyes.

Conclusions
Both anatomical and functional results of zone I ROP treatment in our medical center seem satisfactory. This validates the careful use of IVR as a first-line treatment in zone I ROP. Refractive measurements revealed a high number of myopic eyes both in children treated with IVR alone and in those treated with IVR with deferred LP.

facebook linkedin twitter
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.